Director/PDMR Shareholding- Amendment

RNS Number : 3136C

GlaxoSmithKline PLC

15 January 2015

 

This announcement replaces the original announcement released on 5 January 2015 at 14.30pm (RNS No: 3069B).

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc (the 'Company').

On 31 December 2014, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs in the Company through the annual reinvestment of dividends paid throughout 2014; calculated using an average price of £13.84 per Ordinary Share and $42.91 per ADS:

Non-Executive Director	Ordinary Shares	No. of ADSs
Sir Christopher Gent	6,385.452
Prof Sir Roy Anderson	1,003.260
Dr Stephanie Burns		886.521
Stacey Cartwright	256.043
Lynn Elsenhans		308.422
Judy Lewent		208.857
Sir Deryck Maughan		2,255.597
Dr Daniel Podolsky		1,613.970
Tom de Swaan	1,389.497
Jing Ulrich		98.139
Hans Wijers	76.661

The Company and the Non-Executive Directors were informed of these allocations on 5 January 2015.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

15 January 2015

 

END

 

 

RDSBUGDBUSBBGUU